102 related articles for article (PubMed ID: 19227475)
1. C-peptide normalizes glomerular filtration rate in hyperfiltrating conscious diabetic rats.
Stridh S; Sällström J; Fridén M; Hansell P; Nordquist L; Palm F
Adv Exp Med Biol; 2009; 645():219-25. PubMed ID: 19227475
[TBL] [Abstract][Full Text] [Related]
2. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Nordquist L; Moe E; Sjöquist M
Diabetes Metab Res Rev; 2007 Jul; 23(5):400-5. PubMed ID: 17103462
[TBL] [Abstract][Full Text] [Related]
3. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study.
Huang DY; Richter K; Breidenbach A; Vallon V
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):67-73. PubMed ID: 11862335
[TBL] [Abstract][Full Text] [Related]
4. Effects of C-peptide on renal function at the early stage of experimental diabetes.
Sjöquist M; Huang W; Johansson BL
Kidney Int; 1998 Sep; 54(3):758-64. PubMed ID: 9734600
[TBL] [Abstract][Full Text] [Related]
5. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
[TBL] [Abstract][Full Text] [Related]
6. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Sjöquist M
Kidney Int; 2001 Oct; 60(4):1258-65. PubMed ID: 11576340
[TBL] [Abstract][Full Text] [Related]
7. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption.
Nordquist L; Brown R; Fasching A; Persson P; Palm F
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1265-72. PubMed ID: 19741019
[TBL] [Abstract][Full Text] [Related]
8. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
[TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin on experimental diabetic nephropathy.
Moel DI; Safirstein RL; McEvoy RC; Hsueh W
J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
[TBL] [Abstract][Full Text] [Related]
10. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance.
Qi Z; Whitt I; Mehta A; Jin J; Zhao M; Harris RC; Fogo AB; Breyer MD
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F590-6. PubMed ID: 14600035
[TBL] [Abstract][Full Text] [Related]
11. In vivo quantitative visualization analysis of the effect of C-peptide on glomerular hyperfiltration in diabetic rats by using multiphoton microscopy.
Nakamoto H; Kajiya F
Microcirculation; 2013 Jul; 20(5):425-33. PubMed ID: 24003455
[TBL] [Abstract][Full Text] [Related]
12. Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.
Luippold G; Beilharz M; Mühlbauer B
Nephrol Dial Transplant; 2001 Jul; 16(7):1350-6. PubMed ID: 11427624
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure early in diabetes depends on a balance between glomerular filtration rate and the renin-angiotensin system.
Rojas M; Bell TD; Sturgis LC; Springfield V; Janardhanan R; Fleming C; Brands MW
Am J Hypertens; 2006 Dec; 19(12):1249-55. PubMed ID: 17161770
[TBL] [Abstract][Full Text] [Related]
14. C-peptide replacement improves weight gain and renal function in diabetic rats.
Rebsomen L; Pitel S; Boubred F; Buffat C; Feuerstein JM; Raccah D; Vague P; Tsimaratos M
Diabetes Metab; 2006 Jun; 32(3):223-8. PubMed ID: 16799398
[TBL] [Abstract][Full Text] [Related]
15. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
16. Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats.
Luippold G; Beilharz M; Wehrmann M; Unger L; Gross G; Mühlbauer B
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):420-7. PubMed ID: 15887004
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A₁-receptor deficient mice.
Sällström J; Eriksson T; Fredholm BB; Persson AE; Palm F
Acta Physiol (Oxf); 2014 Feb; 210(2):440-5. PubMed ID: 23901799
[TBL] [Abstract][Full Text] [Related]
18. Effect of L-dopa decarboxylase inhibitor benserazide on renal function in streptozotocin-diabetic rats.
Pfeil K; Staudacher T; Luippold G
Kidney Blood Press Res; 2006; 29(1):43-7. PubMed ID: 16636577
[TBL] [Abstract][Full Text] [Related]
19. Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats.
Zhang PL; Mackenzie HS; Troy JL; Brenner BM
J Am Soc Nephrol; 1994 Feb; 4(8):1564-70. PubMed ID: 8025230
[TBL] [Abstract][Full Text] [Related]
20. L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.
Persson P; Fasching A; Teerlink T; Hansell P; Palm F
Hypertension; 2014 Aug; 64(2):323-9. PubMed ID: 24866144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
